Technavio has been monitoring the global malaria rapid diagnostic devices market since 2016 and the market is poised to grow by USD 100.02 million during 2019-2023, progressing at a CAGR of over 5% during the forecast period.

Download the free sample report @ http://bit.ly/2MVjwfs

The market is driven by the increasing awareness programs conducted by several organizations. In addition, the initiation of government support and funds for early diagnosis of malaria is anticipated to further boost the growth of the malaria rapid diagnostic devices market.

Various developing countries are focusing on creating awareness about malaria and its diagnostics through the implementation of strategic plans. This is encouraging private and public organizations to conduct screening procedures for malaria, which in turn, is driving the adoption of rapid malaria diagnostic devices. Thus, the increasing awareness programs by several organizations are expected to drive the market during the forecast period.

Major Five Malaria Rapid Diagnostic Devices Market Companies:

Abbott

Abbott owns and operates businesses under various segments such as cardiovascular and neuromodulation, diagnostics, nutritionals, and established pharmaceuticals. The company offers Alere malaria Ag Pf test, which helps in the sensitive identification of low parasitemic individuals, with and without evident symptoms of malaria.

bioMérieux

bioMérieux owns and operates businesses under various segments such as microbiology, immunoassays, molecular biology, and industrial applications. The company offers VIKIA Malaria Ag Pf/Pan, which is a rapid test for the qualitative detection of the Plasmodium pathogen in human whole blood specimens.

Bio-Rad Laboratories

Bio-Rad Laboratories has business operations under various segments, namely life science, clinical diagnostics, and other operations. The company offers OptiMAL-IT, which is a reference immunochomatographic rapid diagnostic test based on Plasmodium antigen detection for the diagnosis of malaria.

QIAGEN

QIAGEN has business operations under various segments, namely consumables and related and automation platforms and instruments. The company offers artus Malaria RG PCR Kit, which is a ready-to-use detection kit for real-time PCR and provides the necessary copy number of Plasmodium DNA.

Sight Diagnostics

Sight Diagnostics introduced the ‘Parasight’ Malaria Detection Platform in collaboration with BD in India during April 2016. The company offered Parasight that provides an accurate, cost-effective, and simple-to-use solution that delivers diagnostic accuracy for malaria.

Get the Complete Report @ http://bit.ly/33GDaTq

Malaria Rapid Diagnostic Devices Product Outlook (Revenue, USD Million, 2019 - 2023)

• Consumables
• Systems

Malaria Rapid Diagnostic Devices Regional Outlook (Revenue, USD Million, 2019 - 2023)

• Asia
• Europe
• North America
• ROW

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com